Cargando…

Antiviral response within different cell types of the CNS

The central nervous system (CNS) is a constitutive structure of various cell types conserved by anatomical barriers. Many of the major CNS cell-type populations distributed across the different brain regions are targets for several neurotropic viruses. Numerous studies have demonstrated that viral s...

Descripción completa

Detalles Bibliográficos
Autores principales: Telikani, Zahra, Monson, Ebony A., Hofer, Markus J., Helbig, Karla J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706196/
https://www.ncbi.nlm.nih.gov/pubmed/36458002
http://dx.doi.org/10.3389/fimmu.2022.1044721
_version_ 1784840462049214464
author Telikani, Zahra
Monson, Ebony A.
Hofer, Markus J.
Helbig, Karla J.
author_facet Telikani, Zahra
Monson, Ebony A.
Hofer, Markus J.
Helbig, Karla J.
author_sort Telikani, Zahra
collection PubMed
description The central nervous system (CNS) is a constitutive structure of various cell types conserved by anatomical barriers. Many of the major CNS cell-type populations distributed across the different brain regions are targets for several neurotropic viruses. Numerous studies have demonstrated that viral susceptibility within the CNS is not absolute and initiates a cell-type specific antiviral defence response. Neurons, astrocytes, and microglial cells are among the major resident cell populations within the CNS and are all equipped to sense viral infection and induce a relative antiviral response mostly through type I IFN production, however, not all these cell types adopt a similar antiviral strategy. Rising evidence has suggested a diversity regarding IFN production and responsiveness based on the cell type/sub type, regional distinction and cell`s developmental state which could shape distinct antiviral signatures. Among CNS resident cell types, neurons are of the highest priority to defend against the invading virus due to their poor renewable nature. Therefore, infected and uninfected glial cells tend to play more dominant antiviral roles during a viral infection and have been found to be the major CNS IFN producers. Alternatively, neuronal cells do play an active part during antiviral responses but may adopt differential strategies in addition to induction of a typical type I IFN response, to minimize the chance of cellular damage. Heterogeneity observed in neuronal IFN responsiveness may be partially explained by their altered ISGs and/or lower STATS expression levels, however, further in vivo studies are required to fully elucidate the specificity of the acquired antiviral responses by distinct CNS cell types.
format Online
Article
Text
id pubmed-9706196
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97061962022-11-30 Antiviral response within different cell types of the CNS Telikani, Zahra Monson, Ebony A. Hofer, Markus J. Helbig, Karla J. Front Immunol Immunology The central nervous system (CNS) is a constitutive structure of various cell types conserved by anatomical barriers. Many of the major CNS cell-type populations distributed across the different brain regions are targets for several neurotropic viruses. Numerous studies have demonstrated that viral susceptibility within the CNS is not absolute and initiates a cell-type specific antiviral defence response. Neurons, astrocytes, and microglial cells are among the major resident cell populations within the CNS and are all equipped to sense viral infection and induce a relative antiviral response mostly through type I IFN production, however, not all these cell types adopt a similar antiviral strategy. Rising evidence has suggested a diversity regarding IFN production and responsiveness based on the cell type/sub type, regional distinction and cell`s developmental state which could shape distinct antiviral signatures. Among CNS resident cell types, neurons are of the highest priority to defend against the invading virus due to their poor renewable nature. Therefore, infected and uninfected glial cells tend to play more dominant antiviral roles during a viral infection and have been found to be the major CNS IFN producers. Alternatively, neuronal cells do play an active part during antiviral responses but may adopt differential strategies in addition to induction of a typical type I IFN response, to minimize the chance of cellular damage. Heterogeneity observed in neuronal IFN responsiveness may be partially explained by their altered ISGs and/or lower STATS expression levels, however, further in vivo studies are required to fully elucidate the specificity of the acquired antiviral responses by distinct CNS cell types. Frontiers Media S.A. 2022-11-15 /pmc/articles/PMC9706196/ /pubmed/36458002 http://dx.doi.org/10.3389/fimmu.2022.1044721 Text en Copyright © 2022 Telikani, Monson, Hofer and Helbig https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Telikani, Zahra
Monson, Ebony A.
Hofer, Markus J.
Helbig, Karla J.
Antiviral response within different cell types of the CNS
title Antiviral response within different cell types of the CNS
title_full Antiviral response within different cell types of the CNS
title_fullStr Antiviral response within different cell types of the CNS
title_full_unstemmed Antiviral response within different cell types of the CNS
title_short Antiviral response within different cell types of the CNS
title_sort antiviral response within different cell types of the cns
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706196/
https://www.ncbi.nlm.nih.gov/pubmed/36458002
http://dx.doi.org/10.3389/fimmu.2022.1044721
work_keys_str_mv AT telikanizahra antiviralresponsewithindifferentcelltypesofthecns
AT monsonebonya antiviralresponsewithindifferentcelltypesofthecns
AT hofermarkusj antiviralresponsewithindifferentcelltypesofthecns
AT helbigkarlaj antiviralresponsewithindifferentcelltypesofthecns